Literature DB >> 18162350

Shengmai San reduces hepatic lipids and lipid peroxidation in rats fed on a high-cholesterol diet.

Hsien-Tsung Yao1, Yi-Wei Chang, Chiung-Tong Chen, Meng-Tsan Chiang, Ling Chang, Teng-Kuang Yeh.   

Abstract

Shengmai San (SMS), which is comprised of the medicinal herbs of Panax ginseng C.A. Meyer, Schisandra chinensis Baill., and Ophiopogon japonicus Ker-Gawl (2:1:2)., is a traditional Chinese medicine being used for treating coronary heart disease. The aim of this study was to investigate the effects of SMS on the plasma and liver lipids, lipid peroxidation and antioxidant systems in liver and heart of cholesterol-fed rats. Rats were fed on a high-cholesterol (0.5%) diet (control group), high-cholesterol diet containing 2% SMS (2% SMS group) and 4% SMS (4% SMS group) for four weeks. The oxidative stress marker (thiobarbituric acid reactive substances, TBARS) and antioxidant defense systems including glutathione (GSH), glutathione peroxidase (GSH-Px), glutathione-S-transferase (GST) and superoxide dismutase (SOD) activities in rat liver and heart were evaluated. Results showed that rats fed with SMS-containing diet had reduced the H(2)O(2)-induced erythrocytes susceptibility to hemolysis, and 4% SMS feeding rats had higher plasma GSH concentration compared to the animals fed with the control diet. However, SMS had no effect on plasma lipids (total cholesterol, triglyceride and high-density lipoprotein cholesterol) and TBARS concentration. On the other hand, rats fed with the 4% SMS diet reduced the hepatic cholesterol and triglyceride contents. Fecal bile acid excretion was significantly increased in rats fed with the SMS-containing diet. Higher hepatic GSH and lower TBARS concentrations were observed in rats fed with the 4% SMS diet compared with the rats fed with the control diet. No significant difference in activities of GSH-Px, GST and SOD was found in liver and heart after the SMS treatment. Results from this study indicate that the SMS may reduce hepatic lipids and lipid peroxidation in rats.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18162350     DOI: 10.1016/j.jep.2007.10.043

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  10 in total

1.  Baccaurea angulata fruit inhibits lipid peroxidation and induces the increase in antioxidant enzyme activities.

Authors:  Maryam Abimbola Mikail; Idris Adewale Ahmed; Muhammad Ibrahim; Norazlanshah Hazali; Mohammad Syaiful Bahari Abdul Rasad; Radiah Abdul Ghani; Ridzwan Hashim; Ridhwan Abdul Wahab; Solachuddin Jahuari Arief; Muhammad Lokman Md Isa; Samsul Draman; Mohammad Noor Adros Yahya
Journal:  Eur J Nutr       Date:  2015-06-20       Impact factor: 5.614

2.  Effect of Shengmai injection () on diaphragmatic contractility in doxorubicin-treated rats.

Authors:  Min Ge; Ying-yan Fang; Guo-ping Liu; Su-dong Guan
Journal:  Chin J Integr Med       Date:  2012-08-18       Impact factor: 1.978

3.  Lipid-lowering and antioxidative activities of aqueous extracts of Ocimum sanctum L. leaves in rats fed with a high-cholesterol diet.

Authors:  Thamolwan Suanarunsawat; Watcharaporn Devakul Na Ayutthaya; Thanapat Songsak; Suwan Thirawarapan; Somlak Poungshompoo
Journal:  Oxid Med Cell Longev       Date:  2011-09-21       Impact factor: 6.543

4.  A metabolomic study of rats with doxorubicin-induced cardiomyopathy and Shengmai injection treatment.

Authors:  Yu Chen; Yong Tang; Ya-Chen Zhang; Xiao-Hong Huang; Yu-Quan Xie; Yin Xiang
Journal:  PLoS One       Date:  2015-05-04       Impact factor: 3.240

5.  Pharmacokinetic compatibility of ginsenosides and Schisandra Lignans in Shengmai-san: from the perspective of p-glycoprotein.

Authors:  Yan Liang; Yuanyuan Zhou; Jingwei Zhang; Tai Rao; Lijun Zhou; Rong Xing; Qian Wang; Hanxu Fu; Kun Hao; Lin Xie; Guangji Wang
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

Review 6.  A review on the traditional Chinese medicinal herbs and formulae with hypolipidemic effect.

Authors:  Tung-Ting Sham; Chi-On Chan; You-Hua Wang; Jian-Mei Yang; Daniel Kam-Wah Mok; Shun-Wan Chan
Journal:  Biomed Res Int       Date:  2014-07-07       Impact factor: 3.411

7.  Pharmacokinetic Comparison of 20(R)- and 20(S)-Ginsenoside Rh1 and 20(R)- and 20(S)-Ginsenoside Rg3 in Rat Plasma following Oral Administration of Radix Ginseng Rubra and Sheng-Mai-San Extracts.

Authors:  Xiaomei Fan; Yan Xu; Danni Zhu; Yibing Ji
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-23       Impact factor: 2.629

8.  Exploring the mechanism of Shengmai Yin for coronary heart disease based on systematic pharmacology and chemoinformatics.

Authors:  Yan Jiang; Qi He; Tianqing Zhang; Wang Xiang; Zhiyong Long; Shiwei Wu
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

9.  Clinical Evaluation of a Novel Tablet Formulation of Traditional Thai Polyherbal Medicine Named Nawametho in Comparison with Its Decoction in the Treatment of Hyperlipidemia.

Authors:  Patcharawalai Jaisamut; Channong Tohlang; Subhaphorn Wanna; Acharaporn Thanakun; Thawatchai Srisuwan; Surasak Limsuwan; Wissava Rattanachai; Jarinee Suwannachot; Sasitorn Chusri
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-03       Impact factor: 2.650

10.  Ginseng in traditional herbal prescriptions.

Authors:  Ho Jae Park; Dong Hyun Kim; Se Jin Park; Jong Min Kim; Jong Hoon Ryu
Journal:  J Ginseng Res       Date:  2012-07       Impact factor: 6.060

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.